Contributor:

Hydrus Microstent: Trimodal MoA

Gus Gazzard, MA(Cantab), MD, MBBChir, FRCOphth

Visual Field Progression in the LiGHT Trial

Gus Gazzard, MA(Cantab), MD, MBBChir, FRCOphth

New Trends in the Treatment of PCO, Glaucoma, and Dry Eye

Prof. Mario de La Torre; Dr. Anas-Alexis Benyoussef; Prof. Gus Gazzard; Prof. Pablo Dighiero

SLT as First-Line Therapy for POAG & OH

Prof. Gus Gazzard

New Trends in the Treatment of PCO, Glaucoma, and Dry Eye

Dr. Anas-Alexis Benyoussef; Prof. Gus Gazzard; Prof. Pablo Dighiero; and Prof. Mario de La Torre

Glaucoma Laser Assisted Solutions: Toward a Dropless Future

Prof. Gus Gazzard; Prof. Florent Aptel; Prof. Mark Latina

SLT as First-Line Therapy

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Gus Gazzard, MA(Cantab), MD, MBBChir, FRCOphth

LiGHT: Efficacy and Cost Effectiveness

Gus Gazzard, MD, FRCOphth, Sarwat Salim, MD